Clinical evaluation of carbenicillin in the treatment of infection due to anaerobic bacteria.
D000005:Abdomen; D000293:Adolescent; D000328:Adult; D000368:Aged; D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002228:Carbenicillin / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010388:Pelvis; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002228:Carbenicillin